Cite

HARVARD Citation

    van Berge Henegouwen, J. et al. (2022). Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer. European journal of cancer. pp. 114-123. [Online]. 
  
Back to record